Abstract:NAD+ is a critical factor in multiple biological functions. Poly(ADP‐ribose) polymerase‐1 (PARP‐1), a major NAD+‐consuming enzyme, plays a key role in oxidative stress‐induced cell death. Our previous study has indicated that NAD+ administration can greatly decrease ischemic brain injury, while the mechanisms underlying the effect remain unclear. In this study we tested our hypothesis that NAD+ treatment can attenuate the oxidative stress‐induced, PARP‐mediated ATP depletion, which may underlie the protective effects of NAD+ on brain ischemia. Our study shows that H2O2 treatment can significantly decrease intracellular ATP levels in PC12 cells, which was largely prevented by treatment of NAD+. In contrast, nicotinamide ‐‐‐ the degradation product of NAD+, produce weaker protection against the ATP depletion compared with NAD+, suggesting that NAD+ does not produce its effect on the ATP levels by producing nicotinamide. We also found that PARP inhibitors can prevent the H2O2‐induced ATP depletion, suggesting that NAD+ treatment can prevent the oxidative stress‐induced, PARP‐mediated ATP depletion in PC 12 cells. We also found that neither pyruvate nor antioxidants can attenuate the ATP depletion, arguing against the possibility that NAD+ restores the ATP levels by enhancing antioxidantion capacity of the cells or by increasing glycolysis. Collectively, our study has suggested that NAD+ treatment can restore the ATP levels in cells exposed to oxidative stress, which may at least partially underlie the protective effects of NAD+ on ischemic brain damage. (Supported by a Key Research Grant of Shanghai Municipal Scientific Committee #08JC1415400, and a Shanghai Engineering Center Grant of Equipment and Technology of Physical Therapy for Major Diseases)..

Nad+ Induces C6 Glioma Cell Death by Generating Oxidative Stress and Increasing Intracellular Calcium Concentrations

NAD+ Treatment Decreases Tumor Cell Survival by Inducing Oxidative Stress.

Nadh Can Induce Necrosis of C6 Glioma Cells and Neuro2a Cells

NAD+ Treatment Induces Tumor Cell Necrosis by P2X7 Receptor‐Independent Pathways

NADPH Treatment Induces Profound Necrosis of C6 Glioma Cells

NAD+ Induces Autophagy of Neuro2a Cells by Increasing Oxidative Stress

NAD+ Treatment Can Prevent Multiple Rotenone‐induced Apoptotic Changes of PC12 Cells

NAD+ Treatment Can Block Rotenone‐induced Nuclear Apoptotic Changes of PC12 Cells

NAD+ Treatment Can Prevent Rotenone-Induced Increases in DNA Damage, Bax Levels and Nuclear Translocation of Apoptosis-Inducing Factor in Differentiated PC12 Cells

NAD+ Blocks H2O2‐induced HMGB1 Translocation of PC12 Cells and Decreases Survival of Microglia

Delayed Treatment of NAD+ Can Restore Intracellular ATP Levels and Prevent PC12 Cell Death Induced by Oxidative Stress

NAD+ Treatment Prevents Rotenone-Induced Apoptosis and Necrosis of Differentiated PC12 Cells

Oxidative Stress and PARP Activation Mediate the NADH-induced Decrease in Glioma Cell Survival.

NAD+ Treatment Induces Delayed Autophagy in Neuro2a Cells Partially by Increasing Oxidative Stress

NAD+ depletion radiosensitizes 2-DG-treated glioma cells by abolishing metabolic adaptation

Nad Plus Treatment Can Attenuate The Oxidative Stress-Induced, Parp-Mediated Atp Depletion In Pc12 Cells

Nad(+)/Nadh Metabolism And Nad(+)-Dependent Enzymes In Cell Death And Ischemic Brain Injury: Current Advances And Therapeutic Implications

Glutamine Improves Oxidative Stress through the Wnt3a/ β -Catenin Signaling Pathway in Alzheimer's Disease In Vitro and In Vivo.

NAD+ treatment can increase directly the antioxidant capacity of rotenone-treated differentiated PC12 cells

Ndrg2 Is A Novel P53-Associated Regulator Of Apoptosis In C6-Originated Astrocytes Exposed To Oxygen-Glucose Deprivation

Nad(+)-Carrying Mesoporous Silica Nanoparticles Can Prevent Oxidative Stress-Induced Energy Failures Of Both Rodent Astrocytes And Pc12 Cells